In situ self-assembled stimulus-responsive and conductive hydrogel modulate myocardial infarction inflammatory homeostasis via PPARα/NFκB signaling and enhance the therapeutic efficacy of hiPSC-CMs

Authors:
  • DLDongping Liu
    Dongping Liu
  • MYMingyu Yang
    Mingyu Yang
  • JLJie Liu
    Jie Liu
  • HLHaodong Li
    Haodong Li
  • JRJunting Ren
    Junting Ren
  • XLXiaoping Leng
    Xiaoping Leng
  • XZXiyang Zhang
    Xiyang Zhang
  • QYQi Yu
    Qi Yu
  • SJSongyan Jiao
    Songyan Jiao
  • MGManyu Gong
    Manyu Gong
  • JGJianjun Guo
    Jianjun Guo
  • YZYanwei Zhang
    Yanwei Zhang

Abstract
Stem cell therapies are emerging as promising strategies for repair after myocardial infarction (MI), but the repair efficacy is limited by the poor cardiac microenvironment represented by the inflammatory response, as well as oxidative stress, and adverse electrical coupling. Here, we developed an injectable supramolecular hydrogel (HCPA) that modulates the infarct microenvironment and accelerates myocardial repair by encapsulating human induced pluripotent stem cells derived cardiomyocytes (hiPSC-CMs). HCPA hydrogel not only exhibited excellent reactive oxygen species (ROS) response in order to minimize oxidative stress but also possessed desirable electrical conductivity for the reintegration of electrical impulses. Critically, RNA sequencing demonstrated that the PPARα/NFκB pathway contributed significantly to the HCPA hydrogel-promoted macrophage polarization from M1-type to M2-type, thus alleviating inflammatory responses. HCPA hydrogel harboring hiPSC-CMs increased retention of hiPSC-CMs and improved cardiac function in MI mice. This study represents a new integrated therapeutic option for MI and provides insights for the development of novel biomaterials in the field of tissue engineering.
Funding Information
  • Heilongjiang Provincial Postdoctoral Science Foundation (LBH-Z23212)
  • Harbin Medical University (2024ZD0521501)
  • Harbin Medical University (2024ZD0521500)
  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine (2020-I2M-5-003)
  • National Natural Science Foundation of China (82370417)
  • National Natural Science Foundation of China (82330011)
  • National Natural Science Foundation of China (U22A20346)
  • National Natural Science Foundation of China (U21A20339)
  • National Major Science and Technology Projects of China
  • Natural Science Foundation of Heilongjiang Province (JQ2024H001)
  • Natural Science Foundation of Heilongjiang Province (LH2024H013)
  • China Postdoctoral Science Foundation (2022MD723781)
  • Science Fund for Distinguished Young Scholars of Heilongjiang Province
  • Chinese Academy of Medical Sciences

This publication has 56 references indexed in Scilit: